Prostate Cancer
Roche aiming to launch 6 new products by end 2014
Mar 18, 2010 07:13 EDT
ZURICH (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.
New attack on cancer forces cells to grow old and die
Mar 17, 2010 19:56 EDT
CHICAGO (Reuters) - Instead of killing off cancer cells with toxic drugs, scientists have discovered a molecular pathway that forces them to grow old and die, they said on Wednesday.
VA fined $227K for flawed cancer treatments in Pa.
Mar 17, 2010 17:17 EDT
The Department of Veterans Affairs was fined $227,500 after incorrect radiation doses were given to 97 veterans with prostate cancer at the Philadelphia VA Medical Center, a federal agency announced Wednesday.
VA fined $227K for flawed cancer treatments in Pa.
Mar 17, 2010 17:17 EDT
VA fined $227K for giving wrong radiation doses to vets in Philadelphia with prostate cancer. The Department of Veterans Affairs was fined $227,500 after incorrect radiation doses were given to 97 veterans with prostate cancer at the Philadelphia VA Medical Center, a federal agency announced Wednesday.
Growing doubts over standard prostate cancer test
Mar 13, 2010 14:37 EST
The most commonly used prostate cancer screening procedure, PSA, is at the center of a growing debate after its discoverer said it had become a "hugely expensive public health disaster."
Endo names ex-Nora Therapeutics CEO as COO
Mar 12, 2010 16:56 EST
Endo Pharma hires former Nora Therapeutics and J&J exec McHugh as chief operating officer. Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer.
Experts say even Obama getting too many med tests
Mar 12, 2010 16:30 EST
Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system.
Experts say even Obama getting too many med tests
Mar 12, 2010 16:30 EST
Experts say Americans getting too many medical tests, maybe even President Obama. Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system.
Guidelines: Do medical tests later, less often
Mar 12, 2010 05:35 EST
Recent reports and guideline changes suggest some medical tests should be delayed, avoided, or done less often:
Guidelines: Do medical tests later, less often
Mar 12, 2010 05:35 EST
Are some medical tests overused? Some guidelines are scaling back on frequency, timing. Recent reports and guideline changes suggest some medical tests should be delayed, avoided, or done less often:
Watson says FDA approves 6-month dose Trelstar
Mar 11, 2010 17:50 EST
Watson Pharmaceuticals says FDA approves 6-month dose of prostate cancer drug Trelstar. Watson Pharmaceuticals Inc. said the Food and Drug Administration approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month doses.
Prostate test 'public health disaster': discoverer
Mar 10, 2010 17:11 EST
WASHINGTON (Reuters) - The most commonly used tool for detecting prostate cancer, routine PSA screening, has become "a hugely expensive public health disaster," its discoverer said on Wednesday.
Specialty may bias doctors' prostate cancer advice
Mar 08, 2010 16:42 EST
NEW YORK (Reuters Health) - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives.
Johnny Alf, a Bossa Nova founder, dies at 80
Mar 05, 2010 12:01 EST
Johnny Alf, a founder of Brazil's Bossa Nova music and aficionado of early jazz, dies at 80. A founder of Bossa Nova music has died in Brazil after fighting prostate cancer. He was 80.
Takeda renames heartburn drug to avoid errors
Mar 04, 2010 11:49 EST
FDA says Takeda has agreed to rename Kapidex to avoid confusion with other drugs. Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.
Takeda renames heartburn drug to avoid errors
Mar 04, 2010 11:31 EST
FDA says Takeda has agreed to rename Kadipex to avoid confusion with other drugs. Federal regulators say Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.
Cancer society casts more doubt on prostate tests
Mar 04, 2010 03:38 EST
American Cancer Society casts more doubt on value of regular testing for prostate cancer. Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value too, and can do men more harm than good.
Cancer society casts more doubt on prostate tests
Mar 03, 2010 18:33 EST
Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value too, and can do men more harm than good.
Sanofi drug shows promise against prostate cancer
Mar 03, 2010 18:05 EST
For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.
Sanofi drug shows promise against prostate cancer
Mar 03, 2010 18:05 EST
Experimental drug modestly boosts survival in men with advanced prostate cancer, study finds. For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.
Facts from the Wikipedia page:
| Prostate cancer | |
|---|---|
| Classification and external resources | |
 Micrograph of prostate adenocarcinoma, acinar type, the most common type of prostate cancer. Needle biopsy. HPS stain. | |
| ICD-10 | C61. |
| ICD-9 | 185 |
| OMIM | 176807 |
| DiseasesDB | 10780 |
| MedlinePlus | 000380 |
| eMedicine | radio/574 |
| MeSH | D011471 |
